Life Expectancy News and Research

RSS

Life expectancy is the expected (in the statistical sense) number of years of life remaining at a given age. It is denoted by e''x'', which means the average number of subsequent years of life for someone now aged ''x'', according to a particular mortality experience.

Roche discloses the results of first Phase III clinical study using Taspoglutide

Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen’s Research.

29 Oct 2009

WHO identifies five major causes of premature death

Targeting the five major causes of premature death could increase global life expectancy by almost five years, the WHO said Tuesday, Reuters reports. According to a WHO's Global Health Risks report, which looked at 24 major health risks, "[p]oor childhood nutrition, unsafe sex, alcohol, bad sanitation and hygiene, and high blood pressure are to blame for around a quarter of the 60 million premature deaths around the world each year," the news service writes.

28 Oct 2009

IFPA urges WHO to act on new insights on psoriasis to help millions of psoriasis patients

October 29 is World Psoriasis Day. Conceived by patients for patients, World Psoriasis Day is a truly global event focusing on the burden of living with psoriasis. There are more than 125 million people with psoriasis/psoriatic arthritis in the world. Psoriasis is a severe chronic inflammatory disease that effects all ages, genders, races and ethnicities.

28 Oct 2009

New report on healthcare information technology market released

MarketResearch.com has announced the addition of Kalorama Information's new report, "Healthcare Computer System Markets and Trends In HIT Buying (Forecasts for System, Service and Support Revenues, Areas of Interest, Major Competitor Profiles)," to their collection of Healthcare market reports.

27 Oct 2009

BMC surgeons use new EsophyX TIF for treatment of acid reflux or GERD

Boston Medical Center (BMC) surgeons are now offering patients an incisionless alternative to laparoscopic and traditional surgery for treatment of acid reflux or GERD.

27 Oct 2009

DVD series "Start Fitness Now: Beating Type 2 Diabetes" released

NBC's "Biggest Loser" trainer Kim Lyons announces the newest addition to her fitness empire- 3 title DVD series Start Fitness Now: Beating Type 2 Diabetes and online support forum; produced and distributed by Watch It Now Entertainment.

26 Oct 2009

Reverse mortgages help seniors retain their homes

A survey by the Urban Institute found that 1.9 million seniors found themselves having to choose between buying food and buying medicine. The survey was conducted in 1993—a time when the economy was booming! Due to the current economic woes, it is more difficult than ever for seniors to make it on their own.

24 Oct 2009

Invatec receives approval to market Mo.Ma device

Invatec, a comprehensive innovator of interventional products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Mo.Ma® Ultra Proximal Cerebral Protection Device for use during carotid artery stenting (CAS).

23 Oct 2009

AAFP receives MetLife Foundation grant to counter childhood obesity

The American Academy of Family Physicians (AAFP) and the AAFP Foundation announce that they have been awarded a $150,000 grant from MetLife Foundation, designed to counter the national epidemic of childhood obesity by empowering family physicians with new ways to promote physical activity, nutrition and emotional well-being. The partnership will produce educational materials for children, including books and publications.

23 Oct 2009

CWRU establishes collaborative research center to address common health issues in urban neighborhoods

Case Western Reserve University (CWRU) School of Medicine proudly announces the establishment of the CWRU Prevention Research Center for Healthy Neighborhoods (PRCHN), a collaborative research center to address common health issues faced in disadvantaged urban neighborhoods in and around Greater Cleveland.

22 Oct 2009

On-line portal for training doctors and nurses on fall prevention and protection

Medical Nurse Training, Inc. (www.MedicalNurseTraining.com) is the premier on-line portal for training doctors and nurses on fall prevention and protection.

20 Oct 2009

RA patients who adhere to their prescription drug regimen have better outcome: Study

Rheumatoid arthritis (RA) patients who regularly adhere to their prescription drug regimen have fewer emergency room and doctor visits and incur lower medical costs, according to research presented today by Medco Health Solutions, Inc. at the American College of Rheumatology's Annual Meeting in Philadelphia.

20 Oct 2009

Yashoda Cancer Institute in India to expand use of Varian Medical Systems' RapidArc radiotherapy

A hospital that is using RapidArc radiotherapy to treat cancers of the head & neck and cervix is announcing it will be expanding its use for treatment of other cancers. Yashoda Cancer Institute in Hyderabad has found it can deliver image-guided, intensity modulated radiotherapy (IMRT) faster and more precisely using the RapidArc technology from Varian Medical Systems.

19 Oct 2009

Antisense Pharma's SAPPHIRE Phase III trial evaluating trabedersen approved by Health Canada

The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.

19 Oct 2009

Genentech reports results of ACTEMRA Phase III study for rheumatoid arthritis

Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).

19 Oct 2009

Biogen Idec and Biovitrum to conduct rFIXFc clinical trial in hemophilia B patients

Biogen Idec and Biovitrum AB (STO: BVT) today announced that they plan to advance the companies’ long-acting, fully-recombinant Factor IX Fc fusion protein (rFIXFc) into a registrational clinical trial in hemophilia B patients.

19 Oct 2009

Cultural frameworks and institutional practices for quality health care

As health care moves to the forefront of the national discourse, new research in the social sciences argues that the health of the population and the success or failure of many public health initiatives hinges as much on cultural and social factors as it does on doctors, facilities, or drugs.

19 Oct 2009

Unlike obesity, overweight does not increase mortality rate

Contrary to what was previously assumed, overweight is not increasing the overall death rate in the German population. Matthias Lenz of the Faculty of Mathematics, Computer Science, and Natural Sciences of the University of Hamburg and his co-authors present these and other results in the current issue of Deutsches -rtzeblatt International (Dtsch Artzebl Int 2009; 106[40]: 641𔃆).

19 Oct 2009

Researchers to study gastric banding procedure on overweight, type 2 diabetic patients

In the first trial of its kind in the world, researchers at Monash University's Centre for Obesity Research and Education (CORE) will examine the benefits of a gastric banding procedure on overweight people with Type 2 diabetes.

15 Oct 2009

Public option viable despite the Senate Finance Committee vote

Robert Weiner, former Chief of Staff of the House Committee on Aging and Health Subcommittee, said the public option remains viable despite the Senate Finance Committee vote today.

14 Oct 2009

Life Expectancy News and Research

Further Reading

Roche discloses the results of first Phase III clinical study using Taspoglutide

WHO identifies five major causes of premature death

IFPA urges WHO to act on new insights on psoriasis to help millions of psoriasis patients

New report on healthcare information technology market released

BMC surgeons use new EsophyX TIF for treatment of acid reflux or GERD

DVD series "Start Fitness Now: Beating Type 2 Diabetes" released

Reverse mortgages help seniors retain their homes

Invatec receives approval to market Mo.Ma device

AAFP receives MetLife Foundation grant to counter childhood obesity

CWRU establishes collaborative research center to address common health issues in urban neighborhoods

On-line portal for training doctors and nurses on fall prevention and protection

RA patients who adhere to their prescription drug regimen have better outcome: Study

Yashoda Cancer Institute in India to expand use of Varian Medical Systems' RapidArc radiotherapy

Antisense Pharma's SAPPHIRE Phase III trial evaluating trabedersen approved by Health Canada

Genentech reports results of ACTEMRA Phase III study for rheumatoid arthritis

Biogen Idec and Biovitrum to conduct rFIXFc clinical trial in hemophilia B patients

Cultural frameworks and institutional practices for quality health care

Unlike obesity, overweight does not increase mortality rate

Researchers to study gastric banding procedure on overweight, type 2 diabetic patients

Public option viable despite the Senate Finance Committee vote

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News